Nuo Therapeutics Inc (AURX)
0.75
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Nuo Therapeutics Shareholders Equity (Quarterly): 0.3334M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.3334M |
December 31, 2023 | 1.039M |
September 30, 2023 | 0.7267M |
June 30, 2023 | 0.4708M |
March 31, 2023 | 1.338M |
December 31, 2022 | 2.191M |
September 30, 2022 | 3.151M |
June 30, 2022 | 3.562M |
March 31, 2022 | 0.5272M |
December 31, 2021 | 0.7928M |
September 30, 2021 | -0.5225M |
December 31, 2020 | -0.5158M |
December 31, 2019 | -0.5092M |
September 30, 2019 | -1.285M |
June 30, 2019 | -1.192M |
March 31, 2019 | -0.7119M |
December 31, 2018 | -0.082M |
September 30, 2018 | -0.5818M |
June 30, 2018 | -0.2732M |
March 31, 2018 | -0.1844M |
December 31, 2017 | 0.4829M |
September 30, 2017 | 8.469M |
June 30, 2017 | 6.909M |
March 31, 2017 | 10.81M |
December 31, 2016 | 12.49M |
Date | Value |
---|---|
September 30, 2016 | 14.90M |
June 30, 2016 | 16.81M |
March 31, 2016 | -40.89M |
December 31, 2015 | -36.06M |
September 30, 2015 | 6.033M |
June 30, 2015 | 19.73M |
March 31, 2015 | 20.41M |
December 31, 2014 | 15.97M |
September 30, 2014 | 12.77M |
June 30, 2014 | 16.12M |
March 31, 2014 | 25.53M |
December 31, 2013 | 26.81M |
September 30, 2013 | 30.92M |
June 30, 2013 | 35.64M |
March 31, 2013 | 40.30M |
December 31, 2012 | 38.00M |
September 30, 2012 | 40.19M |
June 30, 2012 | 42.87M |
March 31, 2012 | 10.31M |
December 31, 2011 | 3.282M |
September 30, 2011 | 0.5547M |
June 30, 2011 | 2.511M |
March 31, 2011 | 1.597M |
December 31, 2010 | -0.0793M |
September 30, 2010 | 1.308M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.285M
Minimum
Sep 2019
3.562M
Maximum
Jun 2022
0.6738M
Average
0.5272M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 10.23M |
Perspective Therapeutics Inc | 229.89M |
Protalix BioTherapeutics Inc | 29.79M |
Electromed Inc | 42.54M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.243M |
Total Liabilities (Quarterly) | 0.9094M |
Current Ratio | 1.289 |